Category: freely available

Controversial Australian journalist’s paper flagged by journal

The Journal of Biological Chemistry has added an expression of concern to a 2003 paper that arose from the PhD thesis of a once-prominent — and controversial — science journalist in Australia.

The first author of the paper is Maryanne Demasi, a journalist whose reporting created unintentional headlines in recent years. In 2013, she produced a controversial series about cholesterol and fat (and even cast doubt on cholesterol-lowering drugs known as statins); in 2016, she was fired from the science program Catalyst, after it aired an episode alleging wi-fi could cause brain tumors.

Now, it appears the research community is taking a second look at some of the work underlying her PhD in rheumatology from Royal Adelaide Hospital. Here’s the notice from the journal:

Continue reading Controversial Australian journalist’s paper flagged by journal

UCSF-VA letters to journals offer insight into misconduct investigations

Earlier this month, we reported the retraction of several papers published by researchers with appointments at both the University of California, San Francisco (UCSF) and the San Francisco Veterans Administration (VA) Medical Center, led by a prominent urologist. Recently, we obtained the letters sent to the journals that retracted the papers, shedding some additional light on the case.

The most notable insight: The institutions couldn’t place blame for the misconduct that led to the three retractions on any one individual.

Through a public records request, Retraction Watch has obtained the letter sent to the American Association of Cancer Research (AACR) — which publishes Cancer Research and Clinical Cancer Research — as well as a similar one sent to the editor of the International Journal of Cancer. UCSF and the VA co-wrote both letters and sent them to request editorial action on articles that the research institutions had found to contain “clear evidence” of research misconduct.

Because the retraction notices for the papers published by Cancer Research and Clinical Cancer Research quoted the AACR letter heavily, there isn’t a lot more to reveal. But the letter does say that the committee “could not determine who was responsible” for the misconduct, even though the co-authors said it was Masahiro Sasaki, first author on both papers.

According to the letter, Sasaki:

Continue reading UCSF-VA letters to journals offer insight into misconduct investigations

Prominent food researcher retracts paper from JAMA journal, replaces it with multiple fixes

Brian Wansink

Earlier this week, we reported that high-profile food researcher Brian Wansink — who’s faced months of criticisms about his research — had issued his second retraction. On Thursday, he issued his third.

The retracted paper — a 2012 research letter in the Archives of Pediatrics and Adolescent Medicine, now JAMA Pediatrics — reported that children were more likely to choose an apple over a cookie if the apple included an Elmo sticker. The same day the paper was retracted, Wansink and his co-authors published a replacement version that includes multiple changes, including to the methodology and the results.

The retraction notice lists the mistakes, which the authors say they made “inadvertently:”

Continue reading Prominent food researcher retracts paper from JAMA journal, replaces it with multiple fixes

Reader complaints prompt retraction of meta-analysis of heart-failure drug

A cardiology journal has retracted a 2016 meta-analysis after the editors had an, ahem, change of heart about the rigor of the study.

The article, “Ivabradine as adjuvant treatment for chronic heart failure,” was published in the International Journal of Cardiology, an Elsevier title.

The authors, a group at the Federal University of São Paulo, Brazil, concluded that: Continue reading Reader complaints prompt retraction of meta-analysis of heart-failure drug

“A gut-wrenching experience:” Authors retract, replace JAMA paper

When economist Jason Hockenberry looked at data comparing some of the financial issues facing different U.S. hospitals, he was surprised by what he saw.

Hockenberry was examining the effects of a recently introduced U.S. program that penalizes hospitals with relatively high rates of readmissions for certain conditions by reducing Medicare payments. Although Hockenberry expected hospitals that serve low-income and uninsured patients to have more readmissions (and therefore more penalties), he saw these so-called “safety-net hospitals” had been steadily improving their performance since the program began in 2012, and had faced fewer penalties over time.

The results were so striking, they ended up in JAMA on April 18, 2017. But within one week after publication, Hockenberry learned outside researchers had raised questions about the analysis.

The outside researchers thought the authors had incorrectly categorized some of the safety-net hospitals. After looking into their concerns, Hockenberry — based at Emory University in Atlanta — realized the analysis did contain errors that affect the findings. This week, he and his co-authors retracted the article, replacing it with a corrected version. The new paper still reports that the gap between the penalties faced by safety-net and non-safety-net hospitals is closing — but not for the reasons they initially thought.  

Continue reading “A gut-wrenching experience:” Authors retract, replace JAMA paper

Journal republishes withdrawn paper on emergency care prices, amid controversy

The Annals of Emergency Medicine has republished a controversial paper it withdrew earlier this year which compared the cost of emergency care at different types of facilities.

Because the paper drew heavy criticism when it was originally released, the journal has published a revised version, along with several editorials and discussions between the authors and critics. One point of contention: The analysis stems from data provided by an insurance company — Blue Cross Blue Shield — which it declined to share.

The paper — originally published in February —  caught national attention (and raised concerns among some emergency care providers) when it reported the cost of treatment in emergency departments can be significantly higher than at urgent care centers, even for the same conditions. The journal withdrew the paper in spring, and re-published it Tuesday, with minor changes.

First author Vivian Ho at Rice University told us she made “slight changes”  to some headings, phrases, and the appendix, but:

Continue reading Journal republishes withdrawn paper on emergency care prices, amid controversy

“Devastating:” Authors retract paper in Nature journal upon discovering error

Several years ago, Chris Dames thought he had made an exciting discovery, a “secret sauce” that would allow him to design a device using a novel mechanism.

In a 2014 Nature Communications paper, Dames—who works at the University of California at Berkeley—and his team described the first experimental results for the device, a photon thermal diode. A thermal diode conducts heat in one direction but not in the other, and in theory, could have broad applications—for example, provide barriers that shield buildings from excess heat or use heat to power computers.

But two years later, in August 2016, a colleague thought he had discovered a fundamental error in the design of the experiments. Bair Budaev, who also works at the University of California at Berkeley, believed that the authors made a “a fundamental symmetry error” which invalidated their results. Continue reading “Devastating:” Authors retract paper in Nature journal upon discovering error

Another retraction hits high-profile food researcher under fire

Brian Wansink

It’s been a rough year for Brian Wansink.

Last year, the prominent food researcher posted a blog praising a student for her productivity in his lab. But when Wansink described his methods, readers became concerned that the lab was using improper research techniques to generate more publications. Earlier this year, researchers posted an analysis of four papers by Wansink about pizza consumption to PeerJ, saying they discovered more than 150 inconsistencies in the data. Now, one of those four papers has been retracted.

On Friday, BMC Nutrition posted a brief notice about the 2015 paper, which examined whether people who pay different amounts for all-you-can-eat Italian buffets feel more or less guilty about how much they ate. The notice says the retraction stems from concerns about the data analysis, and the authors do not agree with the journal’s decision.

The new retraction is the second for Wansink, director of the Food and Brand Lab at Cornell.

Here’s the complete retraction notice:

Continue reading Another retraction hits high-profile food researcher under fire

Post-publication peer review in action: Science flags paper just days after publication

Science has issued an expression of concern for a widely covered materials science paper published on Friday, citing issues with the supplementary data.

The paper — which caught the attention of multiple news outlets — added properties to cotton fibers in vitro, potentially enabling researchers to manufacture fabric that can fluoresce or carry magnetic properties.

The move to issue an expression of concern was unusually quick. According to the journal, an expert who received the paper from a journalist under a media embargo contacted Science to flag issues in some of the supplementary data. At the time of this post, the paper does not yet have an entry on PubPeer.

Here’s the full expression of concern:

Continue reading Post-publication peer review in action: Science flags paper just days after publication

Stem cell scientist appealing dismissal loses another paper

Susana Gonzalez

A once-prominent stem cell biologist, who recently lost both her job and a sizable grant, has lost her fifth paper.

Recently, Molecular and Cellular Biology retracted a 2003 paper by Susana Gonzalez. Last February, the National Center for Cardiovascular Research (CNIC) in Spain dismissed her from her position over allegations of misconduct. The reason: suspicions of data manipulation.

As with a previous retraction, the journal said Gonzalez “could not be reached for approval of this retraction.”  

Here’s the full notice:

Continue reading Stem cell scientist appealing dismissal loses another paper